• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Metsera, Inc. - Common Stock (NQ:MTSR)

    70.50 UNCHANGED
    Last Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 70.50
    Bid (Size) 70.58 (2,000)
    Ask (Size) 70.69 (1,100)
    Prev. Close 70.50
    Today's Range 70.50 - 70.50
    52wk Range 51.32 - 83.86
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites ↗
    Optimism also grew around FDA momentum for its palmoplantar pustulosis drug ahead of MoonLake’s Feb. 23 investor day. 
    Via Stocktwits
    News headline image
    Can AI Drive Peloton's Comeback? ↗
    The market is hopping with interesting news. 
    Via The Motley Fool
    Topics Artificial Intelligence

    Performance

    52-Week Range 15.9% below 52-week high
    70.50
    51.3252W Low 83.8652W High

    Metsera, Inc. - Common Stock (MTSR) traded between $51.32 and $83.86 over the past 52 weeks and last traded at $70.50, 15.9% below its 52-week high.

    Past 12 Months
    N/A
    N/A
    N/A
    N/A
    N/A
    +36.4%
    1W  
    1M  
    3M  
    6M  
    YTD  
    1Y +$18.80

    MTSR was +36.4% over the past year.

    12 Months vs Market
    MTSR
    +36.4%
    DIA
    +9.9%
    SPY
    +15.0%
    QQQ
    +23.7%
    IWM
    +15.4%

    Over the past 12 months MTSR returned +36.4% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

    Volume & Liquidity
    1Y
    2.8M

    More News

    Read More
    News headline image
    Down 55%, Should You Buy the Dip on Pfizer? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Is Pfizer Stock a Buy After This $10 Billion Acquisition? ↗
    Via The Motley Fool
    Topics Intellectual Property Lawsuit
    Dow Futures Rise As Senate Votes To End Government Shutdown: MTSR, VSAT, RUM, TSM Among Stocks To Watch ↗
    Via Stocktwits
    Topics Stocks
    News headline image
    Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market ↗
    Via Benzinga
    News headline image
    Ozempic Maker Novo Nordisk Faces Board Shakeup ↗
    Via Benzinga
    News headline image
    Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗
    Via Benzinga
    News headline image
    Why Is Everyone Talking About Novo Nordisk Stock? ↗
    Via The Motley Fool
    News headline image
    Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗
    Via Stocktwits
    Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗
    Via Stocktwits
    News headline image
    Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report ↗
    Via Stocktwits
    News headline image
    Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run ↗
    Via Benzinga
    News headline image
    Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Why Metsera's Share Price Is Plummeting This Week ↗
    Via The Motley Fool
    ‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗
    Via Stocktwits
    News headline image
    Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India ↗
    Via Benzinga
    News headline image
    Where Will Pfizer Be in 3 Years? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗
    Via The Motley Fool
    News headline image
    Shutdown Deal Breathes New Life Into Wall Street ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion ↗
    Via Investor's Business Daily
    Topics Initial Public Offering
    News headline image
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Metsera, Inc. - Common Stock publicly traded?
    Yes, Metsera, Inc. - Common Stock is publicly traded.
    What exchange does Metsera, Inc. - Common Stock trade on?
    Metsera, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Metsera, Inc. - Common Stock?
    The ticker symbol for Metsera, Inc. - Common Stock is MTSR on the Nasdaq Stock Market
    What is the current price of Metsera, Inc. - Common Stock?
    The current price of Metsera, Inc. - Common Stock is 70.50
    When was Metsera, Inc. - Common Stock last traded?
    The last trade of Metsera, Inc. - Common Stock was at 11/13/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.